Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP11A antisense RNA 1 (ATP11A-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 13, transcribed in the antisense direction with respect to the protein-coding ATP11A gene[2][4][8]. It does not encode a protein and is annotated as a non-protein coding transcript. There is currently no published experimental evidence indicating ATP11A-AS1 serves as a direct molecular target in therapeutic contexts—such as receptor, enzyme, transporter, or transcription factor—or that it plays a specific biological role or is implicated in particular diseases[2][4][8]. No drugs, mechanisms of action, biomarker value, or safety concerns are reported for this lncRNA in major biomedical resources. The main available data specify its genomic coordinates and classification as a lncRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP11A antisense RNA 1 (ATP11A-AS1).